TechsoMed

Rehovot, Israel Founded: 2012 • Age: 14 yrs
Ultrasound-based monitoring systems for thermal ablation procedures are developed.

About TechsoMed

TechsoMed is a Healthcare company based in Rehovot (Israel) founded in 2012. Ultrasound-based monitoring systems for thermal ablation procedures are developed. TechsoMed has raised $9.6 million across 3 funding rounds from investors including Screen Holdings, European Union and Axil Capital. TechsoMed offers products and services including BioTrace and BioTrace.IO. Its focus areas include Life Sciences, Surgical Instruments, Cutting and Ablating and Imaging Diagnostics. Its legal entity is TECHSOMED MEDICAL TECHNOLOGIES LTD.

Company details

TechsoMed was founded in 2012 in Rehovot, Israel, and operates in the medical technology sector. Real-time monitoring systems based on ultrasound are developed for thermal ablation procedures. The Biotrace unit, an imaging and analysis tool, is interfaced with standard ultrasound devices to track and predict tissue destruction progression. Operations focus on enabling precise control during ablation treatments in clinical settings.

  • Headquarters Rehovot, Israel
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website techsomed.com
  • Social LinkedIn
  • Legal Name Techsomed Medical Technologies Ltd
Key Metrics
  • Total Equity Funding
    $9.6M (USD)

    in 3 rounds

  • Latest Funding Round
    $7M (USD), Series B

    Mar 2021

  • Investors

Products & Services of TechsoMed

TechsoMed offers a comprehensive portfolio of products and services, including BioTrace and BioTrace.IO.

BioTrace
Medical Software

Software for predicting tissue response in ablation therapy.

BioTrace.IO
Ablation Planning Software

Tool for planning and confirming treatments in oncology.

Funding Insights of TechsoMed

TechsoMed has successfully raised a total of $9.6M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $7 million completed in March 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $9.6M
  • Total Rounds 3
  • Last Round Series B β€” $7M
  • First Round $2.6M

    (May 2019)

  • Investors Count 11

All 3 funding rounds of TechsoMed with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Mar 2021$7MSeries B–Axil Capital
Dec 2019$54,723Grant––
May 2019$2.6MSeries A–Johnson & Johnson Innovation
Valuation history

11 investors in total: 11 institutional.

Investors in TechsoMed

TechsoMed has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Screen Holdings, European Union and Axil Capital.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Early-stage investments are targeted by Axil Capital, a VC firm.
axilcapital.comMinato City, Japan
yongjin.com.cn
Investment firm backed by the Cohen family
cobroventures.comMclean, United States
Tech focused stage agnostic VC firm investing globally
radiancapital.comNew York, United States
Early-stage high-tech startups in Israel are funded by NextLeap Ventures.
nextleapventures.comIsrael
Venture capital firm backed by Johnson & Johnson
jnjinnovation.com/jjdcCambridge, United States
Tailored financial solutions are provided by Magna Capital.
magnacapital.co.ukLondon, England
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
1958europa.euBrussels, Belgium
jnjinnovation.com
Semiconductor, display, and graphic arts equipment is manufactured.
1868screen.co.jpKyoto, Japan
Premium access

Investor details for TechsoMed

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of TechsoMed

17 people are tracked at TechsoMed (8 in leadership, 5 in board & advisors, 4 in team).

NameRoleGroup
Tom Edlund
Chief Technology OfficerLeadership
Tal Sitbon
Deputy Chief Executive OfficerLeadership
Eran Naveh
Chief Strategy OfficerLeadership
Tobias Preusser
General Manager Techsomed GmbhLeadership
Talia Goshen
Director, Contracts & LicensingLeadership
Yossi Abu
Founder and CEOLeadership
Dubi Finklshtein
VP Of SalesLeadership
Nitzan Even
Director Of Marketing And Business DevelopmentLeadership
Arie Rosenfeld
ChairmanBoard & advisors
Wang Chong
DirectorBoard & advisors
Fred Shane
DirectorBoard & advisors
Eiji Kakiuichi
DirectorBoard & advisors
Todd Kaloudis
DirectorBoard & advisors
Torben Pätz
Software DeveloperTeam
Christian Schumann
Software DeveloperTeam
Christian Rieder
Software ManagerTeam
Inbal Amitai
Clinical ManagerTeam
Premium access

Complete people profiles for TechsoMed

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of TechsoMed

3 dated milestones of TechsoMed across 9 years, from founding to its latest funding, stage changes and deals.

  1. Founded TechsoMed is founded.
  2. Funding First funding round of $2.6M.
  3. Funding Latest funding round, Series B, of $7.0M.

Top companies in Imaging Diagnostics

2 companies that operate in the same segment as TechsoMed (Imaging Diagnostics) in Israel, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
MR-interfaced ultrasound devices for cancer and neurology treatments are provided.
1999Tirat Carmel, Haifa District, IsraelUSD 574.2 M541
Digital X-ray sources are developed by Nanox for cloud-based diagnostics.
2004Jerusalem, Jerusalem District, IsraelUSD 110.72 MUSD 13.02 M165
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Techsomed

Frequently Asked Questions about TechsoMed

TechsoMed was founded in 2012 and raised its 1st funding round 7 years after it was founded.

TechsoMed is headquartered in Rehovot, Israel. It is registered at Rehovot, Central District, Israel.

TechsoMed is a funded company, having raised a total of $9.6M across 3 funding rounds to date. The company's 1st funding round was a Series A of $2.6M, raised on May 2019.

TechsoMed was founded in 2012 in Rehovot, Israel, and operates in the medical technology sector. Real-time monitoring systems based on ultrasound are developed for thermal ablation procedures. The Biotrace unit, an imaging and analysis tool, is interfaced with standard ultrasound devices to track and predict tissue destruction progression. Operations focus on enabling precise control during ablation treatments in clinical settings.

TechsoMed offers BioTrace and BioTrace.IO.

TechsoMed has 11 investors. Key investors include Screen Holdings, European Union, Axil Capital, Yongjin Group, and Cobro Ventures.

TechsoMed operates through Techsomed Medical Technologies Ltd.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available